NCT05915897View on ClinicalTrials.gov

Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

TerminatedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

May 23, 2023

Primary Completion Date

March 25, 2024

Study Completion Date

March 25, 2024

Conditions
Chronic Granulomatous Disease
Interventions
DIAGNOSTIC_TEST

Specimen Donation

blood donation

Trial Locations (1)

01801

Sanguine BioSciences, Inc., Woburn

Sponsors
All Listed Sponsors
lead

Sanguine Biosciences

INDUSTRY

NCT05915897 - Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD) | Biotech Hunter | Biotech Hunter